Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Pemphigoid
Clinical narrative: Was covered in rash and blisters/Bullous pemphigoid; This is a spontaneous report received from a Consumer or other non HCP.  A 74-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Dec2022 at 10:00 as dose 5 (booster), single (Lot number: fp2540) at the age of 73 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: BNT162b2 (Dose 1, single, Batch/Lot No: p8120, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM), administration date: 03Mar2021, when the patient was 71-year-old, for COVID-19 immunization; BNT162b2 (Dose 2, single, Lot: ER8730), administration date: 29Mar2021, when the patient was 71-year-old, for COVID-19 immunization; BNT162b2 (Dose 3 (Booster), single, Lot: F82590), administration date: 11Dec2021, when the patient was 72-year-old, for COVID-19 immunization; BNT162b2 (Dose 4 (Booster), single, Lot no: FN2908), administration date: 15Jul2022, when the patient was 72-year-old, for COVID-19 immunization, reaction(s): "Mental exhaustion", "sinus issues", "Bullious Pemhoid", "Nervous", "Wheezing", "Nasal discharge", "Despondent", "Depressed mood". The following information was reported: PEMPHIGOID (hospitalization, disability, medically significant), outcome "recovered with sequelae", described as "Was covered in rash and blisters/Bullous pemphigoid". The patient was hospitalized for pemphigoid (hospitalization duration: 1 day(s)). The events "was covered in rash and blisters/bullous pemphigoid" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Blood test: Bullous pemphigoid, notes: Dermatologist he took blood work and told me that I had Bullous pemphigoid. Therapeutic measures were taken as a result of pemphigoid.  Clinical information: Seriousness Criteria-Caused/prolonged hospitalization and Disabling/Incapacitating was yes. The patient did not have COVID prior vaccination. The patient did not have COVID tested post vaccination. The patient Known allergies was reported as not sure. The patient did not receive any other vaccine in four weeks. Other medications in two weeks were blood pressure pills. After 2nd booster, the patient developed a rash on her arm and sinus issues in 22Aug2022 after the booster which the patient received in 15Jul2022, the patient keep going to dermatologist and ENT, throughout the rest of in 22Jan the patient went to another Dermatologist he took blood work and told me that the patient had Bullous pemphigoid which is cause by a chemical in the body that her immune system was fighting by this time the patient was covered in rash and blisters. The patient felt so despondent and depressed that if was not a Godly person the patient would have committed death. The patient had 3 infusions and a host of medication, prednisone etc. This was a trying time in her life. The first Dr did not understand what was going on and he had the nerve to ask if the patient had a STD. Event treatment Rituxamad Infusion.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300115521 Same patient/vaccine, different dose/event;